This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 22 Apr 2016  |  Asia Pacific  |  Market Research

    ASEAN Pharmaceutical Regulatory Landscape

    ASEAN Economic Community (AEC) to Push Free Flow of Goods, Services and Investments, Creating $160 Billion Opportunity

    This study aims is to analyse the ASEAN pharmaceutical regulatory landscape in terms of the ease of doing business, the impact of harmonisation post AEC 2015, and the key factors and dynamics influencing member countries and the outside world. It also provides strategic recommendations for market participants and conclusions. An overview of the reg...

    $3,000.00
  2. 19 Apr 2016  |  Europe  |  Market Research

    European Cardiac Catheterisation Labs Market, 2016

    Changing Demographics and Reimbursement Policies to Generate Opportunities for Private Sector Growth

    The objective of this study is to present a comprehensive landscape of cardiac cathlabs in Europe, with respect to total PCI centres, pPCI centres, and key trends. The regional scope of this analysis is focused on major European countries, including Western European countries such as the United Kingdom, Germany, France, Italy, and Spain. The Easter...

    $3,000.00
  3. 18 Apr 2016  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Healthcare Outlook, 2016

    Clinical Wearables, Regenerative Medicines and Biosimilars Set for Strong Growth

    Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments which shoulder the largest burden of paying for healthcare services will take decisive steps to innovate their healthcare systems in order to face future challen...

    $4,950.00
  4. 18 Apr 2016  |  Africa  |  Market Outlook

    Africa Healthcare Industry Outlook, 2016

    Value-based Transformations in Home Diagnostic Technologies, Exclusive Drugs, and Improved Point of Care Energise Healthcare Ecosystem

    Africa is experiencing a plethora of changes in the healthcare segment. From being the market of imports and low-value manufacturing, the continent is transforming into a region of tailor-made medical equipment that is compatible with telemedicine solutions. There is an increase in the in-country production of pharmaceuticals, smart phone applicati...

    $4,950.00
  5. 18 Apr 2016  |  Europe  |  Market Research

    Visible Light Imaging and Operating Room Informatics Market, Forecast to 2019

    Growth Potential Expands as Innovative Medical Technologies Become a Must-Have Across Multiple Medical Procedures

    This study covers the global market for visible light (VL) imaging informatics and operating room (OR) imaging informatics. The latter pertain to digital and integrated operating rooms having intra-operative imaging capabilities, which are driven by increasing adoption of image-guided surgery (IGS) and minimally invasive surgery (MIS) techniques. T...

    $3,000.00
  6. 08 Apr 2016  |  North America  |  Market Research

    Global Intensive Care Unit Infrastructure—Comparative Analysis, 2015

    Trends Highlight Urgent Need for Cost-effective Critical Care Strategies, Tilt toward Higher ICU Bed Utilization Rates and Reduced Length of Stay (LOS)

    Intensive care units (ICUs) are primarily for managing patients with acute or lifethreatening disease or conditions. The critical care provided in the ICUs depends upon the resource availability such as skilled personnel and reliable advanced therapeutic and monitoring equipments. Hence, ICUs contribute to a significant amount of spending despite b...

    $3,000.00
  7. 04 Apr 2016  |  Global  |  Market Research

    Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

    This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

    $450.00
  8. 29 Mar 2016  |  Global  |  Market Research

    Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative

    Multi-billion dollar technologies ready to propel industries and transform our world

    Research Overview The Top 50 Emerging Technologies research is a comprehensive analysis of the most promising and disruptive technologies poised to impact our world in the next few years. It highlights and offers strategic guidance and actionable ideas on the hottest 50 technologies that pack maximum potential to fuel global innovation; spawn in...

    $7,500.00
  9. 18 Mar 2016  |  North America  |  Market Research

    Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

    Additional Clinical Trials Critical to Building on Early Promise

    As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...

    $450.00
  10. 18 Mar 2016  |  North America  |  Market Research

    Vital Signs - Drug Development Focus on Genetically Modified Swine

    Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs

    The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...

    $450.00